reviewNature Reviews Clinical OncologyMay 15, 2019BRONZE OA

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

FMFilipe MartinsSLSofiya LatifyanGPGerasimos P. SykiotisFLFaïza LamineMHMichel H. Maillard

University Hospital of Lausanne · École Polytechnique Fédérale de Lausanne · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,217
total citations
FWCI
91.62
Percentile
100%
References
172
Citations per year

Authors

17

Topics & keywords

Topics
Keywords
  • Medicine
  • Adverse effect
  • Intensive care medicine
  • Disease
  • Epidemiology
  • Immunology
  • Immunotherapy
  • Immune checkpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding